Current paradigms in employing self-assembled structures: Drug delivery implications with improved therapeutic potential
Ajay Sharma,Manoj Singh,Varruchi Sharma,Amit Vashishth,Mayank Raj,Sushil K. Upadhyay,Sandeep Singh,Seema Ramniwas,Kuldeep Dhama,Anil K. Sharma,Shashi Kant Bhatia
DOI: https://doi.org/10.1016/j.colsurfb.2024.113745
IF: 5.999
2024-01-20
Colloids and Surfaces B Biointerfaces
Abstract:Recent efforts have focused on developing improved drug delivery systems with enhanced therapeutic efficacy and minimal side effects. Micelles, self-assembled from amphiphilic block copolymers in aqueous solutions, have gained considerable attention for drug delivery. However, there is a need to further enhance their efficiency. These micelles offer benefits like biodegradability, biocompatibility, sustained drug release , and improved patient compliance. Yet, researchers must address stability issues and reduce toxicity. Nanoscale self-assembled structures have shown promise as efficient drug carriers, offering an alternative to conventional methods. Fine-tuning at the monomeric and molecular levels, along with structural modifications, is crucial for optimal drug release profiles. Various strategies, such as entrapping hydrophobic drugs and using polyethylene oxide diblock copolymer micelles to resist protein adsorption and cellular adhesion, protect the hydrophobic core from degradation. The polyethylene oxide corona also provides stealth properties, prolonging blood circulation for extended drug administration. Amphiphilic copolymers are attractive for drug delivery due to their adjustable properties, allowing control over micelle size and morphology. Emerging tools promise complex and multifunctional platforms. This article summarizes about the challenges as far as the use of micelles is concerned, including optimizing performance, rigorous pre-clinical and clinical research, and suggests further improvement for drug delivery efficacy.
materials science, biomaterials,biophysics,chemistry, physical